Showing results (121-130 of 604) with videos related to
Sort By:
Pageof 61
Arthritis and Rheumatism|December 1, 2007
Association of an IRF5 gene functional polymorphism with Sjögren's syndromeCorinne Miceli-Richard, Emmanuelle Comets, Pascale Loiseau, et al.Rheumatology (Oxford, England)|February 7, 2025
Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD)Benjamin Thoreau, Arthur Renaud, Philippe Chafey, et al.The European Respiratory Journal|September 14, 2018
Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertensionJason Weatherald, Athénaïs Boucly, David Launay, et al.Plos One|May 16, 2018
Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosisDavid Launay, David Montani, Paul M Hassoun, et al.Rheumatology (Oxford, England)|February 17, 2022
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?Amber Vanhaecke, Maurizio Cutolo, Oliver Distler, et al.European Radiology|October 6, 2006
Imaging features of musculoskeletal involvement in systemic sclerosisNathalie Boutry, Eric Hachulla, Claire Zanetti-Musielak, et al.Journal of Clinical and Experimental Hematopathology : JCEH|June 20, 2014
Elevated plasma fibrinogen in clinically asymptomatic unicentric Castleman's disease: a case reportAnne Bauters, Moshe Rogosnitzky, Eric Hachulla, et al.Chest|August 31, 2017
Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus: Results From the French Pulmonary Hypertension RegistryEric Hachulla, Xavier Jais, Gaël Cinquetti, et al.Chest|June 7, 2024
Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic SclerosisAmalia Colalillo, Eric Hachulla, Chiara Pellicano, et al.The Journal of Rheumatology|May 9, 2008
Therapeutic strategy combining intravenous cyclophosphamide followed by oral azathioprine to treat worsening interstitial lung disease associated with systemic sclerosis: a retrospective multicenter open-label studyAlice Bérezné, Brigitte Ranque, Dominique Valeyre, et al.Pageof 61